IL102534A0 - Retroviral protease inhibitors - Google Patents
Retroviral protease inhibitorsInfo
- Publication number
- IL102534A0 IL102534A0 IL102534A IL10253492A IL102534A0 IL 102534 A0 IL102534 A0 IL 102534A0 IL 102534 A IL102534 A IL 102534A IL 10253492 A IL10253492 A IL 10253492A IL 102534 A0 IL102534 A0 IL 102534A0
- Authority
- IL
- Israel
- Prior art keywords
- protease inhibitors
- retroviral protease
- retroviral
- inhibitors
- protease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
- C07D233/92—Nitro radicals attached in position 4 or 5
- C07D233/95—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by nitrogen atoms, attached to other ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73156391A | 1991-07-17 | 1991-07-17 | |
US87097592A | 1992-04-20 | 1992-04-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL102534A0 true IL102534A0 (en) | 1993-01-14 |
Family
ID=27112266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL102534A IL102534A0 (en) | 1991-07-17 | 1992-07-17 | Retroviral protease inhibitors |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0602069A4 (en) |
JP (1) | JPH07500577A (en) |
AP (1) | AP9200410A0 (en) |
AU (1) | AU2412992A (en) |
CA (1) | CA2113644A1 (en) |
IE (1) | IE922316A1 (en) |
IL (1) | IL102534A0 (en) |
MX (1) | MX9204233A (en) |
PT (1) | PT100704A (en) |
WO (1) | WO1993002057A1 (en) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6825169B1 (en) | 1991-10-22 | 2004-11-30 | Trustees Of Tufts College | Inhibitors of dipeptidyl-aminopeptidase type IV |
US5888992A (en) * | 1992-03-11 | 1999-03-30 | Narhex Limited | Polar substituted hydrocarbons |
US6071895A (en) * | 1992-03-11 | 2000-06-06 | Narhex Limited | Polar-substituted hydrocarbons |
WO1993018006A1 (en) * | 1992-03-11 | 1993-09-16 | Narhex Limited | Amine derivatives of oxo- and hydroxy-substitued hydrocarbons |
DE69333270T2 (en) | 1992-03-11 | 2004-08-05 | Narhex Ltd. | AMINE DERIVATIVES OF OXO AND HYDROXY SUBSTITUTED CARBON HYDROGEN |
GB9207380D0 (en) * | 1992-04-03 | 1992-05-13 | Ici Plc | Compounds |
US5559256A (en) * | 1992-07-20 | 1996-09-24 | E. R. Squibb & Sons, Inc. | Aminediol protease inhibitors |
ES2068739B1 (en) * | 1993-01-21 | 1995-11-01 | Smithkline Beecham Corp | RETROVIRABLE PROTEASE INHIBITORS. |
IL110898A0 (en) * | 1993-09-10 | 1994-11-28 | Narhex Australia Pty Ltd | Polar-substituted hydrocarbons |
US6222043B1 (en) | 1995-06-30 | 2001-04-24 | Japan Energy Corporation | Methods of preparing novel dipeptide compounds or pharmaceutically acceptable salts thereof |
US5932550A (en) * | 1995-06-30 | 1999-08-03 | Japan Energy Corporation | Dipeptide compound or pharmaceutically acceptable salt thereof and medical use thereof |
US5965532A (en) | 1996-06-28 | 1999-10-12 | Trustees Of Tufts College | Multivalent compounds for crosslinking receptors and uses thereof |
EP0900566A4 (en) | 1996-12-27 | 2001-04-25 | Japan Energy Corp | Novel tripeptide compounds and anti-aids drugs |
AU745687B2 (en) * | 1997-02-26 | 2002-03-28 | Pfizer Inc. | Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of MIP-1-alpha binding to its CCR1 receptor |
US6040145A (en) | 1997-05-07 | 2000-03-21 | Tufts University | Potentiation of the immune response |
US6100234A (en) | 1997-05-07 | 2000-08-08 | Tufts University | Treatment of HIV |
ES2285785T3 (en) | 1997-09-29 | 2007-11-16 | Point Therapeutics, Inc. | STIMULATION OF IN VITRO HEMATOPOYETIC CELLS. |
KR20010052302A (en) | 1998-05-04 | 2001-06-25 | 바바라 피. 월너 | Hematopoietic Stimulation |
ES2189423T3 (en) | 1998-06-05 | 2003-07-01 | Point Therapeutics Inc | BOROPROLINE CYCLING COMPOUNDS. |
US6890904B1 (en) | 1999-05-25 | 2005-05-10 | Point Therapeutics, Inc. | Anti-tumor agents |
EP1666452A2 (en) | 2000-06-30 | 2006-06-07 | Elan Pharmaceuticals, Inc. | Compounds to treat Alzheimer's disease |
PE20020276A1 (en) | 2000-06-30 | 2002-04-06 | Elan Pharm Inc | SUBSTITUTE AMINE COMPOUNDS AS ß-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER |
UY30805A1 (en) * | 2006-12-21 | 2008-07-31 | Bayer Schering Pharma Ag | NON-STEROID MODULATORS OF PROGESTERONE RECEPTORS |
JP2021534180A (en) | 2018-08-16 | 2021-12-09 | イネイト・テューマー・イミュニティ・インコーポレイテッドInnate Tumor Immunity, Inc. | Substituted 4-amino-1H-imidazole [4,5-c] quinoline compound and improved method for its production |
IL309732A (en) | 2021-07-09 | 2024-02-01 | Aligos Therapeutics Inc | Anti-viral compounds |
CN114605320B (en) * | 2022-04-06 | 2023-12-29 | 南京艾康生物科技有限公司 | Synthesis method of 5-nitro-6-methylnicotinic acid ethyl ester |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4431653A (en) * | 1982-03-18 | 1984-02-14 | Hoffmann-La Roche Inc. | Penicillanic acid derivatives |
IE20010533A1 (en) * | 1990-11-20 | 2003-03-05 | Abbott Lab | Intermediates for preparing retroviral protease inhibiting compounds |
-
1992
- 1992-07-16 IE IE231692A patent/IE922316A1/en not_active Application Discontinuation
- 1992-07-17 JP JP5503016A patent/JPH07500577A/en active Pending
- 1992-07-17 EP EP92917238A patent/EP0602069A4/en not_active Withdrawn
- 1992-07-17 AU AU24129/92A patent/AU2412992A/en not_active Abandoned
- 1992-07-17 PT PT100704A patent/PT100704A/en not_active Application Discontinuation
- 1992-07-17 AP APAP/P/1992/000410A patent/AP9200410A0/en unknown
- 1992-07-17 CA CA002113644A patent/CA2113644A1/en not_active Abandoned
- 1992-07-17 WO PCT/US1992/006047 patent/WO1993002057A1/en not_active Application Discontinuation
- 1992-07-17 IL IL102534A patent/IL102534A0/en unknown
- 1992-07-17 MX MX9204233A patent/MX9204233A/en unknown
Also Published As
Publication number | Publication date |
---|---|
PT100704A (en) | 1993-10-29 |
JPH07500577A (en) | 1995-01-19 |
IE922316A1 (en) | 1993-01-27 |
EP0602069A4 (en) | 1995-05-03 |
AU2412992A (en) | 1993-02-23 |
WO1993002057A1 (en) | 1993-02-04 |
AP9200410A0 (en) | 1992-07-31 |
CA2113644A1 (en) | 1993-02-04 |
MX9204233A (en) | 1994-06-30 |
EP0602069A1 (en) | 1994-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA915269B (en) | Retroviral protease inhibitors | |
IL102534A0 (en) | Retroviral protease inhibitors | |
IL90218A0 (en) | Retroviral protease inhibitors | |
ZA929869B (en) | Hiv protease inhibitors | |
EP0580402A3 (en) | Aminediol protease inhibitors | |
HU9601508D0 (en) | Dp-iv-serine protease inhibitors | |
SG46381A1 (en) | Leukoriene biiosynthese inhibitor | |
EP0428849A3 (en) | Retroviral protease inhibitors | |
ZA919439B (en) | Htv protease inhibitors | |
IL108006A0 (en) | Retroviral protease inhibitors | |
ZA899558B (en) | Retroviral protease inhibitors | |
IL100161A0 (en) | Retroviral protease inhibitors derived from 3-chloro-2-chloro-methyl-1-propene | |
ZA949259B (en) | Retroviral protease inhibiting compounds | |
EP0443560A3 (en) | Hiv protease inhibitors | |
EP0628035A4 (en) | Retroviral protease inhibitors. | |
EP0566237A3 (en) | Retroviral protease inhibitors. | |
EP0575500A4 (en) | Hiv protease inhibitors | |
ZA925360B (en) | Retroviral protease inhibitors. | |
IL100083A0 (en) | Retroviral protease inhibitors | |
IL100085A0 (en) | Retroviral protease inhibitors | |
IL105450A0 (en) | Hydroxy-carbamate retroviral protease inhibitors | |
IE894013L (en) | Retroviral protease inhibitors | |
GB9126531D0 (en) | Novel protease | |
ZA924089B (en) | Novel thrombin inhibitors | |
ZA935243B (en) | Aminedediol protease inhibitors |